{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "T",
          "alt": "A",
          "position": "53"
        },
        "variant_string_id": "SNCA T53A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson disease is characterized by the accumulation of aggregated -synuclein as the major component of the Lewy bodies. -Synuclein accumulation in turn leads to compensatory effects that may include the up-regulation of autophagy.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that accumulation of misfolded α-synuclein is a hallmark of Parkinson's disease, establishing a direct link to disease pathogenesis. The paper also states that the compensatory effect of autophagy is seen as a result of accumulation of α-synuclein.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "We found that the activation of macroautophagy in primary cortical neurons that overexpress mutant A53T -synuclein leads to massive mitochondrial destruction and loss, which is associated with a bioenergetic deficit and neuronal degeneration.",
          "judgment": "Yes",
          "reasoning": "The paper uses an autophagy assay in neurons overexpressing the A53T variant.  Given the paper's established link between α-synuclein accumulation and disease, and the observation that overexpressing the mutant form leads to mitochondrial destruction, this assay is appropriate for investigating the functional impact of this variant.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "No mitochondrial removal or net loss was observed when we suppressed the targeting of mitochondria to autophagosomes by silencing Parkin, over-expressing wild-type Mitofusin 2 and dominant negative Dynamin-related protein 1 or blocking autophagy by silencing autophagy-related genes.",
          "judgment": "Yes",
          "reasoning": "The paper describes a control group where autophagy is suppressed or mitochondrial targeting is blocked, serving as a negative control. The statement that 'no mitochondrial removal' was observed in these conditions implies proper baseline measurements were conducted.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "Not stated directly in paper.",
          "judgment": "No",
          "reasoning": "The paper does not provide quantitative statistical measures (OddsPath) related to the observation of increased mitochondrial destruction, so this is the next step.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "No quantitative statistical data pertaining to the mutant A53T -synuclein expression and it’s contribution to the disease was provided in the manuscript.",
          "judgment": "Yes",
          "reasoning": "The paper does not provide quantitative data. As such, there are few controls to judge if this variant exhibits a supporting outcome.",
          "next_step_or_outcome": "Proceed to next step"
        }
      ],
      "overall_assessment": {
        "functional_evidence_strength": "Max PS3_supporting"
      }
    }
  ]
}